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O&:rives. Tk &I. of this study was to explore the possibility 
of quan@3I!b; coronary M flow by myoc3;rr3Ial contrast e&o- 
? with air&Med serum albumin microspheres (pat- 
&~&rovnd. Air-MM albumin microspheres have been pro- 
posed as an intravascular t acer for the study of myocardial 
perfusion by contrast echocardiography. 
Resulls. After dipyridamole, l ft circumflex coronary artery 
Melhods. In six anesthetized opea chest dogs, the left circum. 
flex coronary artery was cannudated and perfused by a roller 
pump with blood from the femoral rtery. air-filled albunnia 
micraspheres (0.4 ml, 2 x I@ sphereslml technetium-Wm- 
labeled albumin were i@cted as a boh~s into the coronary cannula 
at baseline and after treatment with dipyri ole (0.56 mgkg 
body weight intravenously for 4 ein). Two-dimensional echo- 
graphic images of the left ventricular short axis were digitized to 
generate myocardial tinte=intensity curves; myocardial radioactiv- 
ity was measured by an external detector to generate radionucIide 
tirne~activity curves. 
Myocardial contrast echocardiography rovides information 
on myocardial perfusion, which can be useful in a variety of 
clinical conditions. Specifically, contrast echocardiography 
allows evaluation of the presence and extent of collateral 
circulation (l-3), effectiveness of repehsion therapy in pa- 
tients with acute myocardial infarction (4), efficacy of angio- 
plasty procedures (5-7), clptimd time sequence of bypass 
grafting (8) and patency of venous grafts (9,lO). In these 
conditions myocardial contrast echocardiography allows the 
imaging ofmyocardial blood llow distribution. However, con- 
trast echocardiography also has the poiential for deriving 
quantitative nformation  coronary blood flow (11-13). 
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comtrast echo curves were 
perfusion from coronary 
icasrt correlation with coronary 
correlation with core 
mean transit time 0s 
and the measurements 
(,l Am Cdl Cardid 1993;22:20M-21) 
ography with iatracoro~a~y injection of air-filled albums micro- 
spheres. 
The quantitative assessment of coronary blood flow by 
myocardial contrast echocardiography was attempteij in 
previous tudies by csing the intracoronary injection of 
radiographic contrast agents, sonicated by the operator 
immediately before their use (11,12). However, the lack of a 
standardized sonication process might limit the accuracy of 
the measurements. The preparation f contrast agents was 
improved by the advent of standardized, industrially pro- 
duced agents. Recently air-filled human serum aibumin 
microspheres (Albunex) obtained by sonication have aeen 
industrially produced. Tnese microspheres have a mean 
diameter of 4 pm, 95% of them having a diameter ~10 pm 
(14), and their behavior in the microcirculation f the ham- 
ster cheek pouch appears to be very similar to that of red 
blood cells at fluorescent microscopy (15). The latter obser- 
vation supports the use of this echo contrast agent as au 
intravascular tracer for the study of myocardial perfusion by 
echocardiography. T us, the aim of this stud:l was to test the 
possibility of quantifying coronary blood flow by contrast 
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Figure 1. Drawing of the experimental model. h= = line erse$ lo
perfuse the circumflex coronary artery; 
probe ; = line for circumflex “otood pressure measurement. 
we 
sulfate (2 mglkg body weight subcut 
tized with alpha-chloralose ( 
dogs were intubated and ve with oxygen-enriched 
m air by a positive pres 
erial oxygen teosion was 
ioxide tension between 30 
sthesia was maintained by supplemental 
mg of 1 l~ba-~b~oralose, as needed. The 
associated with chloraiose anesthesia w s 
prevented by bolus injections of 8.4% sodium bicarbonate, 
as required. A pressure-tip catheter (Milk 7F) was inserted 
into the abdominal aorta through the right femoral artery. A 
left thoracotomy was performed at the fourth intercostal 
space, the pericardium was excised and the beart suspended 
in the pericardial cradle. The l ft circumflex coronary artery 
was dissected free from the surrounding tissues, and a 
double-lumen steel cannula was inserted into the vessel (Fig. 
i). The dogs -were given heparin sodium (I, U/kg intra- 
venously) before coronary cannulation. The circumflex 
coronary artery was perfused by a calibrated roller pump 
rngh one lumen of the cannula. Arte blood from the 
femoral artery was used as the pe ion source and 
maintained atbody temperature bya thermostatic system. 
Phasic and mean corofiary blood flows were monitored by am 
electromagnetic ffow probe (Zepeda Instruments SWF- 
an external detector, m 
ct of recirculatiork  
were recorded on 
z. The transdlacer 
not held during contrast kjections and data acquisition. 
Echocardiographic images werr: rcco&d on 0.5 in 
recorder for subsequent playback 
. Aii-filled human se- 
) produced by sonica- 
were used as the echocardiographic contrast agent (14). 
These micrmpheres have a mean diameter of4 pm, and 95% 
eter <IO pm. A constant dose of contr 
(0,4 ml) at the concentration f 2 X 108 microsphe 
manually injected into the circuit. The dose of contrast 
was empirically chosen in preliminary observations 
under the same experimental conditions with the same 
scanner and the same controls of the gain setting. Higher 
doses of contrast agent produced transient attenuation arti- 
facts. The whole dose of contrast medium was injected as a 
bolus immediately above the mixing chamber directly into 
ad space in-betweeil (Fig. ii. 
After coronary carmulation, the 
ted in such a way as to equalize 
circumflex to aortic blood pressure. Under these baseline 
conditions, two injections of labeled albumi 
tioas of air-filled albumin microspheres into the coronary 
cannula were performed in each dog. Contrast echo i?iec- 
tions were separated by rf min. Dipyridamole was then 
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intravenously infused at 0.56 mglkg for 4 min. As oon as the 
dipyridamole-induced f&l1 in coronary blood pressure OC- 
curred, the pump flow was increased until the ratio of 
coronary perfusion pressure to aortic pressure was equal- 
ized. Under coronary hyperemia, two injections of labeled 
albumin and six injections of echo contrast agent were made 
into the coronary cannula in each of the six dogs. If a 
decrease in the hyperemic response occurred before com- 
pleting all injections, a supplemental dose of dipyridamole 
(0.28 mg/kg over 2 min) was given. 
Coronary blood flow measurement. Blood flow to the left 
circumflex coronary artery was measured by both the cali- 
brated pump and the electromagnetic flow probe. At the end 
of the experiment, blue Evans dye was injected into the 
circumflex cannula to label the circumflex perfusion terri- 
tory. The weight ofthe stained tissue was used to compute 
the flow per gram ofperfused myocardium. 
Image analysis. Echocardiographic images were digitized 
off line by an array processor-based system for medical 
image processing (Mipron, Kontron). A 256 x 256 pixel 
matrix with 256 gray levels was used. Images were digitized 
at 25 frames/s including at least hree beats before myocar- 
dial contrast appearance and lasted until its visual disappear- 
ance. End-diastolic images were sampled from this sequence 
of images and were stored on a disk (Fig. 2). A region of 
interest, corresponding to the site of myocardial contrast 
opacification, was drawn in each of the sampled end- 
diastolic images. Care was t ken in excluding the specular 
reflectors of endocardial nd epicardial surfaces from this 
region, as well as myocardial reas where evident attenua- 
tion artifacts, if present, occurred. The mean videodensity 
within the region of interest was measured and values 
transferred to a personal computer (Macintosh, Apple) to 
generate myocardial time-intensity curves (Fig. 3). 
Analysis of curves, The curves obtained by technetium- 
99m-labeled albumin were first corrected for recirculation, 
according to well established dgorithms (16). Specifically, 
each curve was subtracted from the background and plotted 
on a semi-log scale, and the descending rectilinear phase 
(that is, before recirculation) was identified. In this interval, 
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Figure 2. End-diastolic echocardiographic im- 
ages in short-axis view at the papillary muscle 
level. Baseline conditions are shown at left; the 
myocardial echo contrast effect is visible be- 
tween the 1 I and 5 o’clock positions in the ri 
panel. 
each curve was fitted by a monoexponential function that 
was extrapolated to I% of peak intensity. A curve corrected 
for recirculation was thus obtained (Fig. 4). The contrast 
echocardiographic curves were analyzed in their aw form, 
that is, without any filtering or correction for recirculation. 
Both technetium-99m-labeled albumin curves and contrast 
echocardiographic curves were analyzed according to the 
same algorithms. The peak value and the rise time (from foot 
to peak intensity) were measured directly. The area under 
the curve was computed by integrating the intensity or 
activity values for the entire curve duration. The mean 
transit time was calculated from each curve according to the 
equation 
2 (t)*(i,) 
t = 1, 
i=- 111, 
tr 
ISit 
t=c 
Figure 3. Myocardial contrast echo time-intensity curve. Both time 
and intensity are displayed in a linear scale. Each data point 
corresponds to a cardiac cycle at end-diastole. 
Video Density 
(gray level 
Ipixol) 
60 
I 
A0 
0 2 i 6 
Time 
(se@ 
JACC Vol. 22, No. 7 
December 1993:2014-21 
too 
80 
60 1 
40 
1 
20 
0 
1 
02 
Time (set) 
Radionuclide myocardial time-activity curve. The original 
curve is displayed with solid circles, and the extrapolated curve, free 
of recirculation, is displayed with open cWks. 
I2 (a)&) is §~mmatio~ of 
d contrast nsity (or activ 
as a function of time (i,) for the entire aeration of the curve 
CtJ, and Z. i, is the summation of co 
ctivity) within the same time interval. 
of the curve and the ratio between its 
contrast intensity were also 6
alysis. To assess the reprodu 
surements derived from contrast echocardiography, t e co- 
efficient of variation was determined in each experiment for 
the two injections of techuet~um-sabered-a~burn~~ nd the six 
injections of air-Wed albumin microspheres under 
conditions. For each dog, the values of each vari 
averaged both at baseline and after d~~yridamo~e 
tion. These averaged values w re used to test th 
between baseline and dipyridamole conditions in the whole 
group of animals by means of the Student t test for paired 
data. The same test was used to compare myocardial transit 
time of labeled albumin with that of air-filled ~bu~n micro- 
spheres. The relation between the inverse of transit time and 
coronary blood flow, both for Labeled albumin and for 
air-filled albumin microspheres, aswell as the relation be- 
tween mean transit ime of air-filled microspheres and Ia- 
beled albumin, were evaluated by least squares linear egres- 
sion analysis. Data are xpressed as mean value 9 1 SD. 
co~d~~~~s, The described e rimental 
pr obtained in all six study dogs. e hemo- 
dynamic conditions after dipyridamole administration were 
significant%y diL _‘___ grant from basehne and were in agreement 
with the known effects of the drug. After dipyridamole, 
coronary blood flow increased (from 1.06 2 0.28 to 3.61 2 
1.43 mlimin per g of myocardium, p -=c CtAl, range 0.62 to 
6.94 mUmin per g); the heart rate increased (from 129 2 38 to
Video Density 
[gray level/pixel) 
1 
1 
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spending to baseline 
yocardial time-activity curves corm- 
cb~les) and to di~y~da~~~e-~~d~~ 
rircks). Each data point c~~~s~0~ds to a
following reasons: poor 
ic images (2 injections), d~s~~a~ernent of theprobe 
shown in Figure 5. Vahtes of 
under the curve, rise time and transit ime for each of 
the 5 I analyzed curves are hown in Table 1. 
rise time and mean t
baseline myocardiail p on from coronary h 
fact, peak intensity significantly increased 
damoie administration (from 45 2 19 to 58 + 
level/pixel, p < 0.05); rise time decreased @on 
significantly different from baseline (135 ? 98 gray levels/ 
pixel x s). Peak intensity, area under the curve and rise time 
did not show any significant correlation with coronary blood 
flow. A weak inverse correlation was found between 
transit ime of albumin microspheres and coronary 
< 0.05, Fig. 6). The latter correlation did 
cal significance if the basehne or 
damole conditions wer: considered separately. No 
cant correiation was found between both the area under th  
descending portion of the curve and the ratio between its 
value and peak contrast intensity and coronary Mood flow. 
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Table 1. Variables Extracted From Each Contrast Echo Time-Intensity Curve 
Basetine Dipyridamole 
Peak Area Under Rise Mean Peak Area Under Rise Mean 
Intensity the Curve Time Transit Time Intensity the Curve Time Transit Time 
(gr. lev.) (gr. lev. x s) (s) (s) (gr. lev.) (gr. lev. x s) (s) (s) 
DogI 42.9 126.1 1.32 2.81 52.7 57.11 0.64 I .87 
62.9 135.53 0.87 2.04 56.8 63.65 0.66 1.50 
38.9 53.92 0.56 1.58 69.4 73.77 0.58 I .70 
51.1 85.39 0.62 2.02 62.2 56.08 0.58 1.58 
50.7 78.88 0.62 1.96 
50.1 100.25 0.87 2.26 
Dog2 46.4 80.7 0.65 2.25 41.4 41.77 0.36 1.26 
43.7 92.47 0.63 1.70 38. I 44.37 0.64 1.17 
44.5 64.45 0.61 2.57 46.0 34.84 0.33 0.95 
30.9 28.52 0.59 1.56 42.4 43.91 0.38 I .09 
25. I 35.8 0.84 1.77 42.2 48.06 0.38 1.12 
Dog3 11.9 23.26 1.06 1.60 15.5 19.08 0.46 1.32 
7,8 18.21 1.00 1.72 21.1 9.78 0.46 1.29 
24.5 37.77 0.50 1.37 31.6 37.88 0.43 0.95 
14. I 24.24 0.53 1.31 23.5 37.13 0.88 1.54 
25.1 23.95 0.42 1.18 
Dog 4 62.9 259.93 1.62 3.66 87.8 201.57 1.00 2.27 
50.4 216.31 I.44 2.76 87.6 409.92 1.96 3.31 
Dog 5 52.6 226.2 2.70 1.64 60.6 208.01 1.35 2.02 
55.2 88.46 0.65 2.08 34.9 100.77 1.32 2.06 
22.9 42.25 0.62 1.64 64.9 181.24 0.88 1.07 
55.6 86.32 0.86 1.44 
71.3 133.86 0.84 1.79 
Dog6 85.6 316.18 1.44 2.57 69.5 184.49 1.08 1.68 
77.8 272.15 1.26 1.90 92.8 367.09 1.29 2.42 
73.0 321.02 1.76 2.63 79.2 150.86 0.70 1.60 
62.6 182.37 0.96 2.37 73.6 222.80 1 .O8 2.01 
66.6 351.22 2.10 2.61 
66.8 182.77 1.26 2.22 
gr. lev. = grade level. 
Technetium~~ro-labeletD albumin. AI1 24 time-activity 
curves obtained with technetium-labeled albumin were of 
adequate quality for the analysis. Two representative curves 
Figure 5. Relation between reverse of mean transit ime (l/t) of 
air-filled albumin microspheres and coronary blood flow. Data 
collected at baseline are displayed with open circles, those collected 
after dipyridamole with solid circks. 
are shown in Figure 7. The values of rise time and mean 
transit time measured from each of these curves are shown 
in Table 2. After dipyridamole, rise time significantly de- 
Figure 7. Radionuclide myocardial time-activity curves correspond- 
ing to baseline (open circles) and to dipyridamole-induced coronary 
hyperemia (solid circles). 
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Dipyridamok 
Wise 
Time 
w 
Mean 
Transit 
The 
ISI 
Rise 
Time 
w 
ean 
Transit 
Time 
M 
Dog I 2.8 4.97 1.0 2.28 
2.2 6.26 1.0 2.47 
Dog 2 4.0 9.09 I.6 2.69 
4.2 8.13 J.2 2.21 
Dog 3 3.6 6.53 0.5 2.09 
1.0 7.92 0.5 2.50 
Dog 4 4.4 10.91 2.5 4.79 
4.2 10.76 2.5 4.05 
Dog 5 5.2 12.02 1.2 3.23 
5.0 11.09 1.2 2.57 
Dog 6 2.0 3.65 0.8 2.26 
2.0 4.47 0.6 1.59 
creased (from 3.38 + 1.27 to ?,%1 1 Q.1 5), and 
ecreased (from 7.98 t 2.92 to 2.73 5 
coefficients [r] = 0.82 h 
time) (Fig. 8). 
Figure 8. Relation between reverse of myocardial mean transit the 
(l/t) of labeled albumin and coronary bIood flow. 
Coronary Blood Flow 
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an accurafe me 
avior of these air- 
survival of sonicate 
dependent (IT), which qeans 
ction in the number 0: she, OH 
levels of myocardial 
er circulatory egions 
stability of these microspheres in the coronary circulation, 
promoting their rapid collapse. However, the exact mecha- 
nisms underlying these findings must be studied in speeifi- 
tally addressed investigaticms. 
The results of this study also diverge 
reports by other laboratories, including otlk 
good correlation between variables extracted Rom myocar- 
dial contrast echocardiography and coronary blood WOW 
(1 i , K!). Sonicated radiographic contrast agents were used in 
these studies; it is well known that hese 
be considered intravascular free flowin 
indirectly demonstrated by their pro10 
sit times (20). With these agents, m 
transit time might reflect bcuh the passage ofbab 
c myocardium, althgh delayed, or th 
bubble size, which can be itizcficcd 51 c 
or flow. or both. Furthermore, the results 
0~s findings (21) of an excellent correlation betW?cta CQrO- 
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nary blood flow and the rate of transit of both labeled red 
blood cells and Albunex microspheres in a study in which 
both technetium-99m-labeled r d blood cells and Albunex 
were injected into the cannulated left anterior descending 
coronary artery of dogs. The reasons for the divergence 
between these and our results are unclear. 
cdtiti~m of tie study. Several factors may have con- 
tribtited to our results, including the equipment used and the 
experimental model. In commercially available scanners the 
ultrasound signal is heavily processed, so that the final 
displayed signal is widely distorted as compared with the 
native signal (22). This distortion may affect the measure- 
ment of myocardial transit ime of a contrast agent. For 
instance, a threshold effect, implemented to reduce the level 
of artifact, may affect he detection f low concentrations of 
contrast agent, artifactually shortening contrast transit time. 
This limitation supports he use of radiofrequency analysis n
contrast echocardiography (13,19,23), which was not per- 
formed in this study. Thus, it cannot be ruled out that 
analysis of the radiofrequency signal might have provided a
better quantitation f coronary blood flow. 
Data on file with the manufacturer show that the pressure 
stability of air-filled albumin microspheres increases with 
increasing concentrations of the agent, whereas ?r 1:2 dilu- 
tion was performed in this study. Again, the effects of the 
different concentrations of the contrast agent o  flow quan- 
titation require further investigations. Similarly, the size of 
microspheres has been evaluated in vitro, and it is still 
unknown whether this size reaains constant in the blood- 
stream or whether it adjusts to the increased pressure in 
vivo. To be as close as possible to the ideal situation f an 
instantaneous injection of a tracer at the inlet of a system, 
the contrast agent was injected as a bolus into the coronary 
cannula. Because of the rise in pressure within the syringe, 
these bolus injections may have affected the stability of 
albumin microspheres. Furthermore, the contrast agent was 
injected manually, whereas a power injection might have 
assured a more homogeneous input function. Finally, the 
injections of labeled albumin and air-filled microspheres 
were not performed simultaneously. In fact, to prevent 
possible effects of albumin microspheres onthe coronary 
circulation, labeled albumin injections always preceded air- 
filled albumin microsphere injections. Thus, the two tracers 
were injected at similar, but not identical, coronary flow 
rates. However, not only were the myocardial transit times 
of these two tracers compared with eac  other, but each of 
them was also compared against the corresponding rates of 
coronary blood flow (Fig. 6 and 8). 
The functional state of the coronary circulation should 
also be considered. TWO widely different conditions were 
compared inthis study: a baseline autoregulating coronary 
bed and one with dipyridamole vasodilation. As a recruit- 
ment Of miCrOvasc&ar units may occur with dipyridam&, 
the volume of distriiiution of the tracers may increase, thus 
limit@ flow quantitation (24). To test this hypothesis, 
coronary blood volume was assessed with the knowledge of
coronary blood flow and mean transit ime of labeled dbu- 
min. A mild increase in coronary blood volume occurred 
with coronary hyperemia (+ 12.4% of baseline) that, how- 
ever, did not reach statistical significance. Still, despite a 
possible slight increment in coronary blood volume with 
coronary hyperemia, these changes did not prevent an 
accurate quantitation of coronary blood flow by labeled 
albumin. Thus, changes in coronary blood volume, if 
present, were not responsible for the limited accuracy of the 
quantitation of coronary blood ow by contrast echocardi- 
ography . 
Previous tudies have also wn that he distribution of
red blood cells and plasma ough the mi~r~cir~ulatio~ 
differs (25,26). Specifically, the transit rate of red blood cells 
through the microcirculation is faster than that of plasma. 
However, this difference is n the range of 10% to 15%, 
whereas our study found a 63% diierence between mean 
transit ime of air-filled albumin microspheres and that of 
technetium-99m-labeled albumin. Furthermore, the close 
correlation between coronary blood flow and transit time of 
labeled albumin indirectly proves that the behavior of ia- 
beled albumin, although not identical, isclose to that of red 
blood cells. 
The measurements derived from contrast echocardiogra- 
phy appear to lack reproducibility, thus contributing tothe 
weak correlation between contrast echo and coronary blood 
flow measurements. However, variability cannot totally 
explain this weak correlation. The coefficient ofvariation for 
mean transit ime was, in fact, 16.5% by albumin micro- 
spheres and 9.796 by labeled albumin, yet a good correlation 
with coronary blood flow existed E;y. ihe raliiotiuclide method 
but not by the. contrast method. Finally, poor reproducibility 
does not erplain the shorter mean transit ime of contrast 
echo comprrred with labeled albumin or the smaller magni- 
tude of changes in response to dipyridamole. 
Implications of the study. This tudy shows the limita- 
tions of air-filled bumin microspheres a an intravascular 
tracer for the quantitation f coronary blood flow based on 
an analysis n the time domain. However, such limitations do 
not rule out the usefulness of air-filled albumin microspheres 
as an echocardiographic contrast agent for studying the 
distribution ofmyocardial perfusion i  the spatial domain. In 
fact, presence, location and extent of myocardial perfusion 
can be assessed by intracoronary Albunex (27). Thus, the 
main indications for the intracoronary injection of this agent 
seem to be the evaluation f the area of myocardium atrisk 
(28), of myocardial nfarct size (29), of collateral circulation 
(l-3), and of the effectiveness of coronary evascularization 
procedures (4). 
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